drug price
-
News
The Food and Drug Administration (FDA) has approved the most expensive drug in the world
The most expensive drug in the world has been approved It is called Hemgenix, it is a gene therapy to treat haemophilia B…
Leggi » -
News
SIFO Congress. New alarm. Rocchi (Egualia): «Pharmaceutical supplies at risk. Serious effects on patients and NHS»
Sifo/ Rocchi Congress: «Pharmaceutical supplies: urgent measures are needed to avoid serious repercussions on patients and NHS» The pharmaceutical sector…
Leggi » -
News
Banco Farmaceutico alarm: "More and more poor people are giving up unreimbursed medicines" Editor's note
The price increase brings Italian families to their knees. A problem that now not only affects food spending but…
Leggi » -
News
Equalia. Equivalent market: uphill road between slow growth and stagnation
The data in the EGUALIA report relating to the 2021 trends. In the North, the highest consumption and the lowest spending on…
Leggi » -
News
The purchase of drugs in the Cnn class: critical issues and addresses at a legal level
In 2012, with the law n. 189, also known as the Balduzzi Decree, the legislator intended to provide a new instrument…
Leggi » -
News
Is evidence-based medicine an illusion? The threat is that Big Pharma's financial interests trump the common good.
Evidence-based medicine has been corrupted by corporate interests, failed regulation and the commercialization of academia, argue Jon Jureidini…
Leggi » -
News
Antitrust. Fine of around 3.5 million euros to the Leadiant group (formerly Sigma-Tau Pharmaceuticals) for abuse of dominant position
According to the Authority, since June 2017 it has imposed unjustifiably heavy prices on the NHS for the sale of a life-saving drug. Analogs…
Leggi » -
News
Lucia Aleotti (Menarini): if the price of drugs drops, the pharmaceutical sector risks default
Pharmaceutical industry, Aleotti denounces the risk of default on money – 18 May 2022 “We are losing competitiveness by leaps and bounds. We…
Leggi » -
News
Seminar Dr. Magrini – AIFA: Access to the drug market
A seminar was held on Wednesday 11 May at the Department of Pharmacy and Biotechnology of the University of Bologna, the speaker…
Leggi » -
News
AIFA: report on timing. An average of 429 days pass from the approval of a drug by the EMA to its marketing in Italy
Report on the timing of drug pricing and reimbursement procedures in the four-year period 2018-2021 AIFA - 13 April 2022 The Agency…
Leggi »